• Skip to primary navigation
  • Skip to main content
  • Skip to footer

LKT Labs

Biochemicals for Life Science Research

  • Products
    • New Products
    • Cancer Biology
    • Cardiovascular
    • Endocrine Signaling and Immunology
    • Metabolic and GI Pathology
    • Microbiology
    • Natural Products
    • Neuroscience
    • Peptides
    • Pharmaceutical Impurities and Derivatives
    • Stem Cell Modulators
  • Services
    • Custom Synthesis
    • Natural Product Isolation
    • Analytical Services
  • Int’l Distributors
  • Support
    • About LKT Labs
    • General Inquiry
    • Bulk Quote Request
    • Document Request
    • Technical Support
    • Catalog Request
    • Product Flyers
  • Contact Us
  • Cart
  • Login / Register
Protocatechuic Acid

Protocatechuic Acid

Product ID P6857
Cas No. 99-50-3
Purity ≥97%
Product Unit SizeCostQuantityStock
25 g $60.00 In stock
50 g $98.00 In stock
100 g $150.00 In stock
Bulk Quote

Quicklinks

  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Description
  • Product Info
  • Shipping and Storage
  • Downloads
  • References
  • Custom Order

Description

Protocatechuic acid is a polyphenol found in many plants and foods; its exhibits anticancer chemotherapeutic, chemopreventive, antiviral, anti-anginal, cardioprotective, antioxidative, and neuroprotective activities. Protocatechuic acid decreases cell migration and invasion of melanoma cells through targeting of PKC/RhoB activation and resulting decreases in NF-κB activation and Matrix metalloproteinase 2 (MMP2) expression. Protocatechuic acid also induces apoptosis in gastric adenocarcinoma cells, increasing activation of JNK and p38 MAPK. Additionally this compound inhibits topoisomerase II. In avian models of infectious bursal disease virus, protocatechuic acid increases lymphocyte proliferation and virus clearance. Protocatechuic acid also displays benefit in ischemic conditions, decreasing fatty acid oxidation in the rodent heart. This compound prevents oxidative stress-induced apoptosis in PC12 neurons as well, inhibiting changes in mitochondrial membrane potential, caspase 3 activation, and decreases in Bcl-2 and glutathione.

Product Info

Cas No.

99-50-3

Purity

≥97%

Formula

C7H6O4

Formula Wt.

154.12

Chemical Name

4-Carboxy-1,2-dihydroxybenzene

IUPAC Name

3,4-dihydroxybenzoic acid

Synonym

3,4-Dihydroxybenzoic acid

Melting Point

200-202°C

Solubility

Slightly soluble in water. Soluble in alcohol or ether.

Appearance

Light Brown Crystalline Powder

Shipping and Storage

Store Temp

Ambient

Ship Temp

Ambient

Downloads

MSDS

P6857 MSDS PDF

Info Sheet

P6857 Info Sheet PDF

References

Kuriyama I, Nakajima Y, Nishida H, et al. Inhibitory effects of low molecular weight polyphenolics from Inonotus obliquus on human DNA topoisomerase activity and cancer cell proliferation. Mol Med Rep. 2013 Aug;8(2):535-42. PMID: 23799608.

Ou CB, Pan Q, Chen X, et al. Protocatechuic acid, a new active substance against the challenge of avian infectious bursal disease virus. Poult Sci. 2012 Jul;91(7):1604-9. Erratum in: Poult Sci. 2012 Oct;91(10):2722. Pang, Q [corrected to Pan, Q]. PMID: 22700505.

Lin HH, Chen JH, Chou FP, et al. Protocatechuic acid inhibits cancer cell metastasis involving the down-regulation of Ras/Akt/NF-κB pathway and MMP-2 production by targeting RhoB activation. Br J Pharmacol. 2011 Jan;162(1):237-54. PMID: 20840540.

Cao YG, Zhang L, Ma C, et al. Metabolism of protocatechuic acid influences fatty acid oxidation in rat heart: new anti-angina mechanism implication. Biochem Pharmacol. 2009 Mar 15;77(6):1096-104. PMID: 19109930.

Liu YM, Jiang B, Bao YM, et al. Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells. Toxicol In Vitro. 2008 Mar;22(2):430-7. PMID: 18082360.

Lin HH, Chen JH, Huang CC, et al. Apoptotic effect of 3,4-dihydroxybenzoic acid on human gastric carcinoma cells involving JNK/p38 MAPK signaling activation. Int J Cancer. 2007 Jun 1;120(11):2306-16. PMID: 17304508.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • G8101

    Guaifenesin

    Expectorant.

    ≥98%
  • T9970

    Tyrphostin AG1295

    PDGFR inhibitor.

    ≥98%
  • S8048

    R-Sulforaphane, Research Grade

    ITC found in cruciferous vegetables; AhR antago...

    97%
  • A9817

    Azelaic Acid

    Dicarboxylic acid found in Arabidopsis; PPARγ ...

    ≥98%
  • D3372

    Disodium Cycloheptylaminomethylene Diphosphate

    Bisphosphonate; squalene synthase inhibitor.

    ≥98%
  • T1855

    Tentoxin

    Cyclic peptide mycotoxin produced by Alternaria...

    ≥98%, HPLC
  • D1774

    Desloratadine

    Loratadine metabolite; FIASMA, histamine H1 ant...

    ≥97%
  • G0250

    cGAMP Disodium [STING Ligand]

    Cyclic dinucleotide that detects cytosolic DNA ...

    ≥98%
  • A5478

    Antipain Dihydrochloride

    Oligopeptide found in Actinomycetes; protease i...

  • T2833

    1-Thio-β-D-glucose Tetraacetate

    Imaging agent; Maillard reaction inhibitor.

    ≥98%
  • F5869

    N-formyl-Met-Ala-Ser

    Peptide, involved in neutrophil activation; FPR...

    ≥95%
  • P7033

    Primaquine Phosphate

    Alters membrane permeability, prevents transpor...

    ≥98% (titration)
  • L8261

    Lupeol

    Triterpene; potential tyrosinase inhibitor.

    ≥98%
  • E5211

    Endomorphin-2

    Endogenous opioid peptide; μOR agonist.

    ≥95%
  • S0072

    5S rRNA modificator

    Electrophile used in 2’-hydroxyl acylation of...

    ≥98%
  • G1646

    Geldanamycin

    HSP90 inhibitor.

    ≥97%
  • P005095

    N-Debenzoylpaclitaxel

    Paclitaxel derivative

    ≥95%
  • G4532

    Gliclazide

    Sulfonylurea; SUR1 antagonist.

    ≥98%
  • M1622

    Mefenamic Acid

    NSAID; GABA-A potentiator, COX-1/2 inhibitor.

    ≥98%
  • D5792

    Doxofylline

    Xanthine derivative; PDE inhibitor.

    ≥98%

Footer

  • Contact Us
  • About Us
  • Site Map
  • Terms and Conditions
LKT Laboratories, Inc.
545 Phalen Blvd.
St. Paul MN, 55130

Ph: (888)-558-5227
Fax: (888)-558-7329

©2026 LKT Laboratories, All Rights Reserved - Products for research use only